title: Identifying risk factors for racial disparities in diabetes outcomes: the translating research into action for diabetes study.
abstract: BACKGROUND
  Versus whites, blacks with diabetes have poorer control of hemoglobin A1c (HbA1c), higher systolic blood pressure (SBP), and higher low-density lipoprotein (LDL) cholesterol as well as higher rates of morbidity and microvascular complications.
  
  
  OBJECTIVE
  To examine whether several mutable risk factors were more strongly associated with poor control of multiple intermediate outcomes among blacks with diabetes than among similar whites.
  
  
  METHODS
  Case-control study.
  
  
  METHODS
  A total of 764 blacks and whites with diabetes receiving care within 8 managed care health plans.
  
  
  METHODS
  Cases were patients with poor control of at least 2 of 3 intermediate outcomes (HbA1c > or =8.0%, SBP > or =140 mmHg, LDL cholesterol > or =130 mg/dL) and controls were patients with good control of all 3 (HbA1c <8.0%, SBP <140 mmHg, LDL cholesterol <130 mg/dL). In multivariate analyses, we determined whether each of several potentially mutable risk factors, including depression, poor adherence to medications, low self-efficacy for reducing cardiovascular risk, and poor patient-provider communication, predicted case or control status.
  
  
  RESULTS
  Among blacks but not whites, in multivariate analyses depression (odds ratio: 2.28; 95% confidence interval: 1.09-4.75) and having missed medication doses (odds ratio: 1.96; 95% confidence interval: 1.01-3.81) were associated with greater odds of being a case rather than a control. None of the other risk factors were associated for either blacks or whites.
  
  
  CONCLUSIONS
  Depression and missing medication doses are more strongly associated with poor diabetes control among blacks than in whites. These 2 risk factors may represent important targets for patient-level interventions to address racial disparities in diabetes outcomes.
authors.affiliation: Division of General Internal Medicine/Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. kduru@mednet.ucla.edu
authors.forename: O Kenrik
authors.initials: OK
authors.lastname: Duru
authors.forename: Robert B
authors.initials: RB
authors.lastname: Gerzoff
authors.forename: Joseph V
authors.initials: JV
authors.lastname: Selby
authors.forename: Arleen F
authors.initials: AF
authors.lastname: Brown
authors.forename: Ronald T
authors.initials: RT
authors.lastname: Ackermann
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Karter
authors.forename: Sonja
authors.initials: S
authors.lastname: Ross
authors.forename: Neil
authors.initials: N
authors.lastname: Steers
authors.forename: William H
authors.initials: WH
authors.lastname: Herman
authors.forename: Beth
authors.initials: B
authors.lastname: Waitzfelder
authors.forename: Carol M
authors.initials: CM
authors.lastname: Mangione
mesh_terms: D001741:Black or African American; D001794:Blood Pressure; D016022:Case-Control Studies; D008078:Cholesterol, LDL / Q000097:blood; D003863:Depression / Q000150:complications; D003920:Diabetes Mellitus / Q000208:ethnology* / Q000523:psychology / Q000628:therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D054625:Healthcare Disparities; D006801:Humans; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D015999:Multivariate Analysis; D011369:Professional-Patient Relations; D012307:Risk Factors; D020377:Self Efficacy
chemical_list: D008078:Cholesterol, LDL; D006442:Glycated Hemoglobin